A carregar...
Sodium‐glucose co‐transporter 2 inhibitors for type 2 diabetes mellitus: An overview for the primary care physician
AIMS: Sodium‐glucose co‐transporter type 2 (SGLT2) inhibitors are a new class of anti‐hyperglycaemic agents in type 2 diabetes mellitus (T2DM). This review examines their mechanism of action and provides an overview of safety and efficacy from the main studies of SGLT2 inhibitors marketed in the Uni...
Na minha lista:
| Publicado no: | Int J Clin Pract |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5518299/ https://ncbi.nlm.nih.gov/pubmed/28440009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12937 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|